What are the Challenges in Targeting Motor Proteins for Cancer Therapy?
While targeting motor proteins holds promise, there are several challenges. One major issue is the specificity of inhibitors, as motor proteins are also essential for normal cellular functions. Off-target effects can lead to toxicity and adverse side effects. Additionally, cancer cells can develop resistance to motor protein inhibitors, necessitating combination therapies or the development of next-generation inhibitors.
